Osaic Holdings
NVAX icon

Osaic Holdings’s Novavax NVAX Stock Holding History

Osaic Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
49,460
+1,517
+3% +$13.6K ﹤0.01% 3731
2026
Q1 		$390K Buy
47,943
+2,142
+5% +$19.4K ﹤0.01% 3590
2025
Q4 		$308K Sell
45,801
-3,522
-7% -$26.6K ﹤0.01% 3788
2025
Q3 		$379K Buy
49,323
+353
+0.7% +$2.75K ﹤0.01% 3662
2025
Q2 		$309K Sell
48,970
-3,205
-6% -$21.2K ﹤0.01% 3574
2025
Q1 		$334K Buy
52,175
+6,891
+15% +$57K ﹤0.01% 3215
2024
Q4 		$364K Buy
45,284
+8,169
+22% +$78.8K ﹤0.01% 3081
2024
Q3 		$469K Buy
37,115
+2,984
+9% +$38.5K ﹤0.01% 2929
2024
Q2 		$432K Sell
34,131
-41,760
-55% -$420K ﹤0.01% 2891
2024
Q1 		$362K Sell
75,891
-4,644
-6% -$21.5K ﹤0.01% 3201
2023
Q4 		$387K Sell
80,535
-5,929
-7% -$36.3K ﹤0.01% 3374
2023
Q3 		$626K Buy
86,464
+10,833
+14% +$86.6K ﹤0.01% 3061
2023
Q2 		$565K Buy
75,631
+11,822
+19% +$93K ﹤0.01% 3043
2023
Q1 		$444K Buy
63,809
+7,770
+14% +$71.5K ﹤0.01% 3205
2022
Q4 		$576K Buy
56,039
+7,747
+16% +$137K ﹤0.01% 2897
2022
Q3 		$878K Sell
48,292
-4,676
-9% -$203K ﹤0.01% 2359
2022
Q2 		$2.73M Sell
52,968
-17,663
-25% -$915K 0.01% 1425
2022
Q1 		$5.08M Sell
70,631
-4,109
-5% -$366K 0.01% 1203
2021
Q4 		$10.7M Buy
74,740
+25,471
+52% +$4.38M 0.02% 711
2021
Q3 		$10.2M Buy
49,269
+3,586
+8% +$790K 0.02% 663
2021
Q2 		$9.7M Sell
45,683
-1,876
-4% -$344K 0.02% 661
2021
Q1 		$8.63M Sell
47,559
-4,643
-9% -$925K 0.02% 665
2020
Q4 		$5.82M Buy
52,202
+19,444
+59% +$2.07M 0.02% 768
2020
Q3 		$3.49M Buy
32,758
+88
+0.3% +$10.7K 0.01% 962
2020
Q2 		$2.72M Sell
32,670
-17,454
-35% -$668K 0.01% 1055
2020
Q1 		$687K Buy
+50,124
New +$424K ﹤0.01% 1816

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Osaic Holdings's NVAX Position: Q2 2026 in Review

Osaic Holdings increased its Novavax (NVAX) stake by 3.2% in Q2 2026, buying an estimated $13.6K and bringing the position to 49,460 shares worth $466K. The position accounts for ﹤0.01% of the portfolio, ranked #3731.

Osaic Holdings first reported a position in NVAX in Q1 2020 and has held it in 26 quarters since. The position peaked at $10.7M in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Osaic Holdings held 49,460 shares of Novavax worth $466K as of Q2 2026.
  • Osaic Holdings bought 1,517 Novavax shares in Q2 2026, an estimated $13.6K.
  • Novavax made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3731 holding.
  • Osaic Holdings first reported a position in Novavax in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Novavax position peaked at $10.7M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.